Alkermes plc - Ordinary Shares (ALKS) News

Alkermes plc - Ordinary Shares (ALKS): $23.43

0.32 (-1.35%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add ALKS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#37 of 357

in industry

Filter ALKS News Items

ALKS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ALKS News Highlights

  • For ALKS, its 30 day story count is now at 10.
  • Over the past 16 days, the trend for ALKS's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about ALKS are MA and TOP.

Latest ALKS News From Around the Web

Below are the latest news stories about ALKERMES PLC that investors may wish to consider to help them evaluate ALKS as an investment opportunity.

Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes

Originally published in Alkermes September 2023 Corporate Responsibility Report NORTHAMPTON, MA / ACCESSWIRE / December 27, 2023 / Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive ...

Yahoo | December 27, 2023

Alkermes (ALKS) Outperforms Broader Market: What You Need to Know

Alkermes (ALKS) reachead $27.92 at the closing of the latest trading day, reflecting a +1.34% change compared to its last close.

Yahoo | December 22, 2023

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.

Yahoo | December 21, 2023

11 Most Promising Psychedelic Stocks According to Hedge Funds

In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds. If you want to skip our overview of the psychedelic industry and the latest news, then you can take a look at the 5 Most Promising Psychedelic Stocks. The ability to use chemicals to alter one’s […]

Yahoo | December 20, 2023

Corporate Governance at Alkermes

NORTHAMPTON, MA / ACCESSWIRE / December 20, 2023 / Alkermes Originally published in Alkermes September 2023 Corporate Responsibility Report Board of Directors Our Board is currently comprised of eleven members, each of whom has a term expiring at ...

Yahoo | December 20, 2023

Alkermes' Commitment to Integrity and Compliance

NORTHAMPTON, MA / ACCESSWIRE / December 18, 2023 / Alkermes Originally published in Alkermes September 2023 Corporate Responsibility Report Ethics and Compliance Integrity is a core Alkermes value and the foundation of the way we do business. Alkermes ...

Yahoo | December 18, 2023

Alkermes' Culture of Employee Engagement and Wellness

NORTHAMPTON, MA / ACCESSWIRE / December 14, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportEmployee engagement remained a top priority for the Company throughout 2022. As many of our office-based employees ...

Yahoo | December 14, 2023

Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk

Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk, a leading global healthcare company. Under the terms of the agreement, upon the closing of the transaction, Alkermes will be entitled to a one-time cash payment of $92.5 million for the facility and related assets, subject to customary adjustments in accordance with the agreement. The transaction is expected to close i

Yahoo | December 14, 2023

12 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates

In this piece, we will take a look at the 12 best growth stocks to buy according to billionaire Ray Dalio’s Bridgewater Associates. If you want to see more stocks in this selection, then take a look at 5 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates. Since founding Bridgewater Associates […]

Yahoo | December 13, 2023

Patient Advocacy and Community Engagement at Alkermes

NORTHAMPTON, MA / ACCESSWIRE / December 11, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportWe have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, ...

Yahoo | December 11, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!